11-17517424-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005709.4(USH1C):​c.1261G>A​(p.Gly421Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00307 in 1,593,664 control chromosomes in the GnomAD database, including 137 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G421D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.015 ( 66 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 71 hom. )

Consequence

USH1C
NM_005709.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.14

Publications

4 publications found
Variant links:
Genes affected
USH1C (HGNC:12597): (USH1 protein network component harmonin) This gene encodes a scaffold protein that functions in the assembly of Usher protein complexes. The protein contains PDZ domains, a coiled-coil region with a bipartite nuclear localization signal and a PEST degradation sequence. Defects in this gene are the cause of Usher syndrome type 1C and non-syndromic sensorineural deafness autosomal recessive type 18. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
USH1C Gene-Disease associations (from GenCC):
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1C
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia
  • autosomal recessive nonsyndromic hearing loss 18A
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026290119).
BP6
Variant 11-17517424-C-T is Benign according to our data. Variant chr11-17517424-C-T is described in ClinVar as Benign. ClinVar VariationId is 45426.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0519 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH1CNM_005709.4 linkc.1261G>A p.Gly421Ser missense_variant Exon 15 of 21 ENST00000318024.9 NP_005700.2 Q9Y6N9-1A0A0S2Z4U9
USH1CNM_153676.4 linkc.1211-1134G>A intron_variant Intron 14 of 26 ENST00000005226.12 NP_710142.1 Q9Y6N9-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH1CENST00000318024.9 linkc.1261G>A p.Gly421Ser missense_variant Exon 15 of 21 1 NM_005709.4 ENSP00000317018.4 Q9Y6N9-1
USH1CENST00000005226.12 linkc.1211-1134G>A intron_variant Intron 14 of 26 5 NM_153676.4 ENSP00000005226.7 Q9Y6N9-5

Frequencies

GnomAD3 genomes
AF:
0.0146
AC:
2225
AN:
152172
Hom.:
66
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0494
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00753
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000367
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00397
AC:
869
AN:
219106
AF XY:
0.00318
show subpopulations
Gnomad AFR exome
AF:
0.0500
Gnomad AMR exome
AF:
0.00328
Gnomad ASJ exome
AF:
0.00287
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000433
Gnomad OTH exome
AF:
0.00449
GnomAD4 exome
AF:
0.00184
AC:
2654
AN:
1441374
Hom.:
71
Cov.:
32
AF XY:
0.00165
AC XY:
1177
AN XY:
714746
show subpopulations
African (AFR)
AF:
0.0539
AC:
1788
AN:
33148
American (AMR)
AF:
0.00374
AC:
158
AN:
42280
Ashkenazi Jewish (ASJ)
AF:
0.00303
AC:
78
AN:
25710
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38924
South Asian (SAS)
AF:
0.000121
AC:
10
AN:
82670
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51872
Middle Eastern (MID)
AF:
0.00421
AC:
24
AN:
5698
European-Non Finnish (NFE)
AF:
0.000310
AC:
342
AN:
1101466
Other (OTH)
AF:
0.00426
AC:
254
AN:
59606
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
155
311
466
622
777
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0147
AC:
2232
AN:
152290
Hom.:
66
Cov.:
32
AF XY:
0.0147
AC XY:
1095
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0494
AC:
2054
AN:
41556
American (AMR)
AF:
0.00752
AC:
115
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000368
AC:
25
AN:
68020
Other (OTH)
AF:
0.0118
AC:
25
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
98
197
295
394
492
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00689
Hom.:
59
Bravo
AF:
0.0168
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.0423
AC:
186
ESP6500EA
AF:
0.000815
AC:
7
ExAC
AF:
0.00434
AC:
526
Asia WGS
AF:
0.00346
AC:
12
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jul 01, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 14, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gly421Ser in Exon 15B of USH1C: This variant is not expected to have clinical si gnificance because it has been identified in 4.3% (162/3734) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs115931035). -

Feb 05, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 12, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 1C Benign:2
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
21
DANN
Benign
0.46
DEOGEN2
Benign
0.045
T;.;.
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.71
FATHMM_MKL
Benign
0.67
D
LIST_S2
Benign
0.68
T;T;T
MetaRNN
Benign
0.0026
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.34
N;.;.
PhyloP100
1.1
PROVEAN
Benign
0.75
N;N;N
REVEL
Benign
0.026
Sift
Benign
0.90
T;T;T
Sift4G
Benign
0.47
T;T;T
Polyphen
0.0050
B;.;B
Vest4
0.14
MVP
0.18
ClinPred
0.0016
T
GERP RS
3.6
Varity_R
0.031
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115931035; hg19: chr11-17538971; API